Financial statements Biomedcomplex
Balance sheet of Biomedcomplex
Company age:
Age:
10 y. 3 m. 5 d.
Share capital:
Share capital:
5 000 PLN
Company suspended its operations from 2025-01-01
Balance sheet data of BIOMEDCOMPLEX
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 142 627,82 | 126 650,17 | 170 995,10 | 143 506,52 | 109 041,71 |
| A. Fixed assets | 101 726,02 | 83 644,04 | 65 562,08 | 56 458,94 | 50 065,92 |
| B. Current assets | 40 901,80 | 43 006,11 | 105 433,02 | 87 047,58 | 58 975,79 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 142 627,82 | 126 650,15 | 170 995,10 | 143 506,52 | 109 041,71 |
| A. Equity | -320 400,46 | -366 706,84 | -391 777,90 | -142 730,65 | -142 305,19 |
| B. Liabilities and provisions for liabilities | 463 028,28 | 493 356,99 | 562 773,00 | 286 237,17 | 265 053,53 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.